Exciting things are happening every day at VCU Massey Cancer Center. We’re saving lives and reducing suffering from cancer. We’re discovering new and better ways to prevent, diagnose and treat cancer. We’re offering opportunities for the community to join us in the progress against cancer.
Updates to outpatient care at Massey due to COVID-19
At VCU Massey Cancer Center we have implemented changes in our clinics to mitigate the coronavirus (COVID-19) situation and keep our patients and medical teams safe.
After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists from Virginia Commonwealth University Massey Cancer Center have found that fingolimod, a drug currently approved for the treatment of multiple sclerosis, could potentially eliminate or reduce the progression of colitis-associated cancer (CAC).
After recently announcing success in eliminating melanoma metastasis in laboratory experiments, scientists at Virginia Commonwealth University Massey Cancer Center have made another important discovery in understanding the process by which the gene mda-9/syntenin contributes to metastasis in melanoma (the spread of skin cancer) and possibly a variety of other cancers.
A new drug combination featuring the widely-known impotence drug Viagra has been found to improve the effectiveness of cancer treatment while protecting the heart from harm caused by a popular form of chemotherapy. With nearly half of all cancer survivors dying from other conditions than cancer, most notably cardiovascular disease, this new treatment is not only innovative but necessary.
Approximately 68 percent of U.S. adults are overweight or obese, according to the National Cancer Institute, which puts them at greater risk for developing cancer, cardiovascular disease, diabetes and a host of other chronic illnesses. But an international team of scientists led by Virginia Commonwealth University Massey Cancer Center researcher Andrew Larner, M.D., Ph.D., has successfully reversed obesity in mice by manipulating the production of an enzyme known as tyrosine-protein kinase-2 (Tyk2).
VCU Massey Cancer Center will jointly provide radiation oncology services at a new cancer center scheduled to open in April 2013 at Spotsylvania Regional Medical Center (SRMC) in Spotsylvania, Va. The two organizations have partnered under an agreement between HCA Virginia Health System and VCU Health System, a component of the VCU Medical Center that delivers Massey’s clinical oncology care.